Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients (MAGNA VICTORIA)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Novo Nordisk A/S
Information provided by (Responsible Party):
M.B. Bizino, MD, principal investigator, Leiden University Medical Center
ClinicalTrials.gov Identifier:
NCT01761318
First received: December 20, 2012
Last updated: October 9, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)